This webinar is a live discussion on the outcomes of the current Medtronic portfolio, sensor innovation goals, and advancing therapy with closed-loop algorithms and integrated systems, followed by Q&A.
This webinar will review Guardian™ Connect system features, real-world data for predictive alerts, and time-in range, and The Sugar.IQ™ diabetes assistant, followed by Q&A.
This webinar discusses the method of SmartGuard™ Auto Mode delivery, best practices for patients, and initiating the MiniMed™ 670G system in your practice, followed Q&A.
ABCs OF MANAGING SMARTGUARD™ AUTO MODE - SESSION 2
This webinar reviews assessing SmartGuard™ Auto Mode, coaching patient behaviors, and making clinician changes, followed by Q&A.
This webinar reviews using the MiniMed™ 670G system to assess situations requiring special considerations, including exercise, high-fat meals, sick days, steroids and outpatient procedures, followed by Q&A.
This webinar reviews the effectiveness of insulin pump therapy in patients with type 2 diabetes, calculating the initial pump start settings, and reviewing the process for initiating patients on pump therapy, followed by Q&A.
This webinar will review the MiniMed™ 630G insulin pump, walkthrough menu navigations, and how to program settings, followed by Q&A.
This webinar reviews patient instructions for the adjustment phase, guidelines for evaluating CareLink™ data and adjusting settings, and case study examples, followed by Q&A.
MiniMed™ 670G System for School Nurses
This training is intended to help school nurses with the basic operation of a student’s MiniMed™ 670G system, including SmartGuard™ Auto Mode. Please note: MiniMed™ 670G system is approved for ages 7+
MiniMed™ 670G System Pediatric Pivotal Trial Results and Case Studies
Dr. Fran Kaufman reviews the results from the pediatric pivotal trial and Dr. Kevin Kaiserman provides key learnings from the pivotal trial and a pediatric case study.
MiniMed™ 670G System Key Learnings and CareLink™ Data Interpretation
Dr. Scott Lee, Endocrinologist at Loma Linda University will provide key learnings for the MiniMed™ 670G system, including how to interpret CareLink™ reports and gain insights using the AIM methodology.
MiniMed™ 670G System: How to Onboard New Patients
Dr. Scott Lee, Endocrinologist at Loma Linda University gives an overview of the MiniMed™ 670G system and demonstrates how to onboard and manage patients to help them reach health goals and improve quality of life.
MiniMed™ 670G Hybrid Closed Loop System CareLink™ Reports and Case Study
Dr. Thomas Blevins demonstrates how to interpret CareLink™ reports and gain insights from real patient case studies.
Pivotal Trial of a Hybrid Closed Loop System in Type 1 Diabetes
Presentation of findings from the HCL pivotal trial of the MiniMed™ 670G system.
MiniMed™ 670G Hybrid Closed Loop System Details
Review of the MiniMed™ 670G system modes of delivery and initiating the system in your practice.
Insulin Pump Therapy - Why and How it Works
Dr. LaShelle Barmore, D.O. discusses the effectiveness of insulin pump therapy particularly for people with type 2 diabetes and how to transition patients from injections.
More information (see more) Less information (see less)
Insulin Pump Therapy for Type 2 Diabetes
Linda Burkett, Senior Global Medical Specialist at Medtronic, presents on the benefits of pump therapy for patients with type 2 diabetes.
MiniMed™ Insulin Pump Therapy: Driving Outcomes for Type 2 Patients
Dr. Robert Vigersky, Chief Medical Officer at Medtronic explains how insulin pump therapy can improve both glucose control and quality of life for patients with type 2 diabetes.
The Sugar.IQ™ Diabetes Assistant
Pratik Agrawal, Medtronic Director of Data Science & Informatics Innovation, discusses how to ease patient burden in daily diabetes management with Sugar.IQ™ Diabetes Assistant.